Structure Therapeutics Inc. American Depositary Shares Cash Flow Reinvestment Rate

Latest as of March 2026: 32.52x

Structure Therapeutics Inc. American Depositary Shares cash flow reinvestment rate. Structure Therapeutics Inc. American Depositary Shares (GPCR) has a Cash Flow Reinvestment Rate of 32.52x as of March 2026, reinvesting $496.95 Million (capex $1.19 Million plus investments $-495.76 Million) from operating cash flow of $15.28 Million. Explore GPCR debt coverage from operations to assess how comfortably operating cash covers total debt obligations.

Reinvestment Rate

32.52x
(Capex + Investments) / Operating CF

Total Reinvested

$496.95 Million
Capex + Investments

Operating Cash Flow

$15.28 Million
USD

Capital Expenditures

$1.19 Million
USD

Structure Therapeutics Inc. American Depositary Shares Cash Flow Reinvestment Rate by Year (None–None)

Structure Therapeutics Inc. American Depositary Shares cash flow reinvestment rate by year from None to None. Year-by-year capital reinvestment analysis for Structure Therapeutics Inc. American Depositary Shares. For the full cash flow conversion analysis, see Structure Therapeutics Inc. American Dep cash conversion from operations.

Year Reinvestment Rate Total Reinvested (USD) Operating CF Capex YoY Change
Cash Flow Reinvestment Rate = (ABS(Capex) + ABS(Investments)) / Operating Cash Flow